Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-02

Clinical Trial Update: A Clinical Study of KLH-2109 in Patients With Endometriosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of KLH-2109 in endometriosis is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KLH-2109

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Endometriosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING